Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02360917 · ClinicalTrials.gov registry record · NA

Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

A NA study of Cancer and Cognition, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT02360917 is a NA study of Cancer and Cognition that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 31 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02360917, a NA study of Cancer and Cognition, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

At Cedars-Sinai Medical Center, we have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2 hours for 6 weeks. The leading neuropsychologist covers material such as guided relaxation, behavioral strategies for automatic/negative thoughts, compensatory strategies for attention and memory, executive functioning, pacing, and balance. Each Haze series will be electronically delivered in a live format to our satellite site, The University of Kansas.

Conditions Studied

Interventions

  • OTHER Emerging from the Haze

Study Locations (1)

California

  • Cedars Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2015-07-06
Est. Completion 2018-05-23
Phase NA

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT02360917

The ClinicalTrials.gov registry entry for NCT02360917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Emerging from the Haze is the first listed.

NCT02360917 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02360917 about?

NCT02360917 is a clinical study titled "Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment". At Cedars-Sinai Medical Center, we have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2 hours fo...

What is the current status of trial NCT02360917?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-07-06. Estimated completion is 2018-05-23.

What conditions does trial NCT02360917 study?

This clinical trial studies the following conditions: Cancer, Cognition.

What interventions are being tested in trial NCT02360917?

The interventions under investigation include: Emerging from the Haze (OTHER).

Who is sponsoring clinical trial NCT02360917?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02360917 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.